Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease

A E Warrington; M Rodriguez

doi:10.1007/978-3-540-73677-6_9

. 2008;318:213–239. doi: 10.1007/978-3-540-73677-6_9

Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease

A E Warrington ², M Rodriguez ¹

Editor: Moses Rodriguez¹

PMCID: PMC7120407 PMID: 18219820

Abstract

Promoting remyelination following injury to the central nervous system (CNS) promises to be an effective neuroprotective strategy to limit the loss of surviving axons and prevent disability. Studies confirm that multiple sclerosis (MS) and spinal cord injury lesions contain myelinating cells and their progenitors. Recruiting these endogenous cells to remyelinate may be of therapeutic value. This review addresses the use of antibodies reactive to CNS antigens to promote remyelination. Antibody-induced remyelination in a virus-mediated model of chronic spinal cord injury was initially observed in response to treatment with CNS reactive antisera. Monoclonal mouse and human IgMs, which bind to the surface of oligodendrocytes and myelin, were later identified that were functionally equivalent to antisera. A recombinant form of a human remyelination-promoting IgM (rHIgM22) targets areas of CNS injury and promotes maximal remyelination within 5 weeks after a single low dose (25 μg/kg). The IgM isoform of this reparative antibody is required for in vivo function. We hypothesize that the IgM clusters membrane domains and associated signaling molecules on the surface of target cells. Current therapies for MS are designed to modulate inflammation. In contrast, remyelination promoting IgMs are the first potential therapeutic molecules designed to induce tissue repair by acting within the CNS at sites of damage on the cells responsible for myelin synthesis.

Keywords: Multiple Sclerosis, Spinal Cord Injury, Experimental Autoimmune Encephalomyelitis, Multiple Sclerosis Lesion, Therapeutic Plasma Exchange

Contributor Information

Moses Rodriguez, Email: rodriguez.moses@mayo.edu.

A. E. Warrington, Email: Warrington.arthur@mayo.edu

M. Rodriguez, Email: rodriguez.moses@mayo.edu

References

1.Aarum J, Sandberg K, Haeberlein SL, Persson MA. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA. 2003;100:15983–15988. doi: 10.1073/pnas.2237050100. [DOI] [PMC free article] [PubMed] [Google Scholar]
2.Akiyama Y, Radtke C, Honmou O, Kocsis JD. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia. 2002;39:229–236. doi: 10.1002/glia.10102. [DOI] [PMC free article] [PubMed] [Google Scholar]
3.Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci. 2002;22:6623–6630. doi: 10.1523/JNEUROSCI.22-15-06623.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
4.Almazan G, Honegger P, Matthieu JM. Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study. Dev Neurosci. 1985;7:45–54. doi: 10.1159/000112275. [DOI] [PubMed] [Google Scholar]
5.Annunziata P, Pluchino S, Martino T, Guazzi G. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis. J Neuroimmunol. 1997;77:128–133. doi: 10.1016/S0165-5728(97)00074-X. [DOI] [PubMed] [Google Scholar]
6.Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq ME. Pre-oligodendrocytes from adult human CNS. J Neurosci. 1992;12:1538–1547. doi: 10.1523/JNEUROSCI.12-04-01538.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
7.Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci . 2001;4:1116–1122. doi: 10.1038/nn738. [DOI] [PubMed] [Google Scholar]
8.Asakura K, Miller DJ, Murray K, Bansal R, Pfeiffer SE, Rodriguez M. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res. 1996;43:273–281. doi: 10.1002/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
9.Asakura K, Miller DJ, Pease LR, Rodriguez M. Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci. 1998;18:7700–7708. doi: 10.1523/JNEUROSCI.18-19-07700.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
10.Bansal R. Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev Neurosci. 2002;24:35–46. doi: 10.1159/000064944. [DOI] [PubMed] [Google Scholar]
11.Bansal R, Winkler S, Bheddah S. Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci. 1999;19:7913–7924. doi: 10.1523/JNEUROSCI.19-18-07913.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]
12.Barouch R, Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 2002;16:1304–1306. doi: 10.1096/fj.01-0467fje. [DOI] [PubMed] [Google Scholar]
13.Barres BA, Lazar MA, Raff MC. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 1994;120:1097–1108. doi: 10.1242/dev.120.5.1097. [DOI] [PubMed] [Google Scholar]
14.Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 1993;118:283–295. doi: 10.1242/dev.118.1.283. [DOI] [PubMed] [Google Scholar]
15.Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D, Abramsky O. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia. 2003;41:73–80. doi: 10.1002/glia.10159. [DOI] [PubMed] [Google Scholar]
16.Bieber AJ, Kerr S, Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann Neurol. 2003;53:680–684. doi: 10.1002/ana.10578. [DOI] [PubMed] [Google Scholar]
17.Bieber AJ, Ure DR, Rodriguez M. Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J Neuropathol Exp Neurol. 2005;64:46–57. doi: 10.1093/jnen/64.1.46. [DOI] [PubMed] [Google Scholar]
18.Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri SV, Pease LR, Rodriguez M. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia. 2002;37:241–249. doi: 10.1002/glia.10033. [DOI] [PubMed] [Google Scholar]
19.Bieber AJ, Warrington A, Pease LR, Rodriguez M. Humoral autoimmunity as a mediator of CNS repair. Trends Neurosci. 2001;24:S39–S44. doi: 10.1016/S0166-2236(00)01991-3. [DOI] [PubMed] [Google Scholar]
20.Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol. 2001;14:271–278. doi: 10.1097/00019052-200106000-00003. [DOI] [PubMed] [Google Scholar]
21.Blakemore WF. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci. 1973;20:63–72. doi: 10.1016/0022-510X(73)90118-4. [DOI] [PubMed] [Google Scholar]
22.Blakemore WF, Crang AJ. Extensive oligodendrocyte remyelination following injection of cultured central nervous system cells into demyelinating lesions in adult central nervous system. Dev Neurosci. 1988;10:1–11. doi: 10.1159/000111949. [DOI] [PubMed] [Google Scholar]
23.Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type- 2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A. 1990;87:6368–6372. doi: 10.1073/pnas.87.16.6368. [DOI] [PMC free article] [PubMed] [Google Scholar]
24.Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab ME. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 1995;378:498–501. doi: 10.1038/378498a0. [DOI] [PubMed] [Google Scholar]
25.Brenner T, Arnon R, Sela M, Abramsky O, Meiner Z, Riven-Kreitman R, Tarcik N, Teitelbaum D. Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone. J Neuroimmunol. 2001;115:152–160. doi: 10.1016/S0165-5728(01)00250-8. [DOI] [PubMed] [Google Scholar]
26.Bruck W, Kuhlmann T, Stadelmann C. Remyelination in multiple sclerosis. J Neurol Sci. 2003;206:181–185. doi: 10.1016/S0022-510X(02)00191-0. [DOI] [PubMed] [Google Scholar]
27.Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, McKay RD. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science. 1999;285:754–756. doi: 10.1126/science.285.5428.754. [DOI] [PubMed] [Google Scholar]
28.Caroni P, Schwab ME. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1988;1:85–96. doi: 10.1016/0896-6273(88)90212-7. [DOI] [PubMed] [Google Scholar]
29.Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci. 2000;20:6404–6412. doi: 10.1523/JNEUROSCI.20-17-06404.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
30.Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med. 2002;346:165–173. doi: 10.1056/NEJMoa010994. [DOI] [PubMed] [Google Scholar]
31.Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000;403:434–439. doi: 10.1038/35000601. [DOI] [PubMed] [Google Scholar]
32.Ciric B, Howe CL, Paz Soldan M, Warrington AE, Bieber AJ, Van Keulen V, Rodriguez M, Pease LR. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol. 2003;13:608–616. doi: 10.1111/j.1750-3639.2003.tb00489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
33.Ciric B, VanKeulen V, Rodriguez M, Kyle RA, Gertz MA, Pease LR. Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. Blood. 2001;97:321–323. doi: 10.1182/blood.V97.1.321. [DOI] [PubMed] [Google Scholar]
34.Cohen IR, Schwartz M. Autoimmune maintenance and neuroprotection of the central nervous system. J Neuroimmunol. 1999;100:111–114. doi: 10.1016/S0165-5728(99)00190-3. [DOI] [PubMed] [Google Scholar]
35.Dal Canto MC, Lipton HL. Multiple sclerosis. Animal model: Theiler’s virus infection in mice. Am J Pathol. 1977;88:497–500. [PMC free article] [PubMed] [Google Scholar]
36.Dodel R, Hampel H, Depboylu C, Lin S, Gao F, Schock S, Jackel S, Wei X, Buerger K, Hoft C, Hemmer B, Moller HJ, Farlow M, Oertel WH, Sommer N, Du Y. Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer’s disease. Ann Neurol. 2002;52:253–256. doi: 10.1002/ana.10253. [DOI] [PubMed] [Google Scholar]
37.Duncan ID. Glial cell transplantation and remyelination of the central nervous system. Neuropathol Appl Neurobiol. 1996;22:87–100. doi: 10.1111/j.1365-2990.1996.tb00852.x. [DOI] [PubMed] [Google Scholar]
38.Dyer CA. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands. Mol Neurobiol. 1993;7:1–22. doi: 10.1007/BF02780606. [DOI] [PubMed] [Google Scholar]
39.Dyer CA, Benjamins JA. Redistribution and internalization of antibodies to galactocerebroside by oligodendroglia. J Neurosci. 1988;8:883–891. doi: 10.1523/JNEUROSCI.08-03-00883.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]
40.Einstein O, Karussis D, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Abramsky O, Ben-Hur T. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci. 2003;24:1074–1082. doi: 10.1016/j.mcn.2003.08.009. [DOI] [PubMed] [Google Scholar]
41.Ellezam B, Bertrand J, Dergham P, McKerracher L. Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve. Neurobiol Dis. 2003;12:1–10. doi: 10.1016/S0969-9961(02)00013-X. [DOI] [PubMed] [Google Scholar]
42.Feigin I, Popoff N. Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system. Neurology. 1966;16:364–372. doi: 10.1212/wnl.16.4.364. [DOI] [PubMed] [Google Scholar]
43.Fernandez M, Giuliani A, Pirondi S, D’Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A. 2004;101:16363–16368. doi: 10.1073/pnas.0407262101. [DOI] [PMC free article] [PubMed] [Google Scholar]
44.Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705–714. doi: 10.1038/nrn917. [DOI] [PubMed] [Google Scholar]
45.Franklin RJ, Gilson JM, Blakemore WF. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J Neurosci Res. 1997;50:337–344. doi: 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]
46.Franklin RJ, Hinks GL, Woodruff RH, O’Leary MT. What roles do growth factors play in CNS remyelination? Prog Brain Res. 2001;132:185–193. doi: 10.1016/S0079-6123(01)32075-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
47.Gaiano N, Fishell G. Transplantation as a tool to study progenitors within the vertebrate nervous system. J Neurobiol. 1998;36:152–161. doi: 10.1002/(SICI)1097-4695(199808)36:2<152::AID-NEU4>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]
48.Goddard DR, Berry M, Butt AM. In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J Neurosci Res. 1999;57:74–85. doi: 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]
49.GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 2000;403:439–444. doi: 10.1038/35000226. [DOI] [PubMed] [Google Scholar]
50.Guimond SE, Turnbull JE. Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides. Curr Biol. 1999;9:1343–1346. doi: 10.1016/S0960-9822(00)80060-3. [DOI] [PubMed] [Google Scholar]
51.Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci. 1972;10:535–546. doi: 10.1242/jcs.10.2.535. [DOI] [PubMed] [Google Scholar]
52.Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci. 2000;20:5283–5291. doi: 10.1523/JNEUROSCI.20-14-05283.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]
53.Herndon RM, Price DL, Weiner LP. Regeneration of oligodendroglia during recovery from demyelinating disease. Science. 1977;195:693–694. doi: 10.1126/science.190678. [DOI] [PubMed] [Google Scholar]
54.Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H. The neuro- protective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol. 2000;107:161–166. doi: 10.1016/S0165-5728(00)00233-2. [DOI] [PubMed] [Google Scholar]
55.Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. Antiapoptotic signal- ing by a remyelination-promoting human antimyelin antibody. Neurobiol Dis. 2004;15:120–131. doi: 10.1016/j.nbd.2003.09.002. [DOI] [PubMed] [Google Scholar]
56.Howe CL, Mayoral S, Rodriguez M. Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1beta. Neurobiol Dis. 2006;23:731–739. doi: 10.1016/j.nbd.2006.06.012. [DOI] [PubMed] [Google Scholar]
57.Huang DW, McKerracher L, Braun PE, David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron. 1999;24:639–647. doi: 10.1016/S0896-6273(00)81118-6. [DOI] [PubMed] [Google Scholar]
58.Hunter SF, Miller DJ, Rodriguez M. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. J Neurol Sci. 1997;150:103–113. doi: 10.1016/S0022-510X(97)00080-4. [DOI] [PubMed] [Google Scholar]
59.Imitola J, Comabella M, Chandraker AK, Dangond F, Sayegh MH, Snyder EY, Khoury SJ. Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. Am J Pathol. 2004;164:1615–1625. doi: 10.1016/S0002-9440(10)63720-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
60.Jeffery ND, Blakemore WF. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol. 1995;24:775–781. doi: 10.1007/BF01191213. [DOI] [PubMed] [Google Scholar]
61.Jeffery ND, Blakemore WF. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain. 1997;120:27–37. doi: 10.1093/brain/120.1.27. [DOI] [PubMed] [Google Scholar]
62.Jeffery ND, Crang AJ, O’Leary M T, Hodge SJ, Blakemore WF. Behavioural conse- quences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord. Eur J Neurosci. 1999;11:1508–1514. doi: 10.1046/j.1460-9568.1999.00564.x. [DOI] [PubMed] [Google Scholar]
63.Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind pla- cebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology. 1995;45:1268–1276. doi: 10.1212/wnl.45.7.1268. [DOI] [PubMed] [Google Scholar]
64.Johnson KP, Brooks BR, Ford CC, Goodman A, Guarnaccia J, Lisak RP, Myers LW, Panitch HS, Pruitt A, Rose JW, Kachuck N, Wolinsky JS. Sustained clinical benefits of glati- ramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler. 2000;6:255–266. doi: 10.1177/135245850000600407. [DOI] [PubMed] [Google Scholar]
65.Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci. 2002;22:2690–2700. doi: 10.1523/JNEUROSCI.22-07-02690.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]
66.Kasahara K, Watanabe K, Takeuchi K, Kaneko H, Oohira A, Yamamoto T, Sanai Y. Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhe- sion molecule TAG-1 signaling in lipid rafts. J Biol Chem. 2000;275:34701–34709. doi: 10.1074/jbc.M003163200. [DOI] [PubMed] [Google Scholar]
67.Kasahara K, Watanabe Y, Yamamoto T, Sanai Y. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingoli- pid in caveolae-like domains. J Biol Chem. 1997;272:29947–29953. doi: 10.1074/jbc.272.47.29947. [DOI] [PubMed] [Google Scholar]
68.Keegan BM, Noseworthy JH. Multiple sclerosis. Annu Rev Med. 2002;53:285–302. doi: 10.1146/annurev.med.53.082901.103909. [DOI] [PubMed] [Google Scholar]
69.Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. Relation between humoral pathologi- cal changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005;366:579–582. doi: 10.1016/S0140-6736(05)67102-4. [DOI] [PubMed] [Google Scholar]
70.Keirstead HS, Blakemore WF. The role of oligodendrocytes and oligodendrocyte pro- genitors in CNS remyelination. Adv Exp Med Biol. 1999;468:183–197. doi: 10.1007/978-1-4615-4685-6_15. [DOI] [PubMed] [Google Scholar]
71.Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neuro- trophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflamma- tion. J Exp Med. 1999;189:865–870. doi: 10.1084/jem.189.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]
72.Khalili K, White MK, Lublin F, Ferrante P, Berger JR. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology. 2007;68:985–990. doi: 10.1212/01.wnl.0000257832.38943.2b. [DOI] [PubMed] [Google Scholar]
73.Kohama I, Lankford KL, Preiningerova J, White FA, Vollmer TL, Kocsis JD. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci. 2001;21:944–950. doi: 10.1523/JNEUROSCI.21-03-00944.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
74.Koshizuka S, Okada S, Okawa A, Koda M, Murasawa M, Hashimoto M, Kamada T, Yoshinaga K, Murakami M, Moriya H, Yamazaki M. Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol. 2004;63:64–72. doi: 10.1093/jnen/63.1.64. [DOI] [PubMed] [Google Scholar]
75.Kotter MR, Setzu A, Sim FJ, Rooijen N Van, Franklin RJ. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia. 2001;35:204–212. doi: 10.1002/glia.1085. [DOI] [PubMed] [Google Scholar]
76.Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112. doi: 10.1016/S0140-6736(04)17551-X. [DOI] [PubMed] [Google Scholar]
77.Lisak RP, Zweiman B, Blanchard N, Rorke LB. Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomy- elitis (EAE) J Neurol Sci. 1983;62:281–293. doi: 10.1016/0022-510X(83)90205-8. [DOI] [PubMed] [Google Scholar]
78.Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, Holekamp TF, McDonald JW. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A. 2000;97:6126–6131. doi: 10.1073/pnas.97.11.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]
79.Lucchinetti C, Bruck W. The pathology of primary progressive multiple sclerosis. Mult Scler. 2004;10([Suppl 1]):S23–S30. doi: 10.1177/135245850401000105. [DOI] [PubMed] [Google Scholar]
80.Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quan- titative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999;122:2279–2295. doi: 10.1093/brain/122.12.2279. [DOI] [PubMed] [Google Scholar]
81.Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707–717. doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
82.Lucchinetti CF, Brueck W, Rodriguez M, Lassmann H. Multiple sclerosis: lessons from neuropathology. Semin Neurol. 1998;18:337–349. doi: 10.1055/s-2008-1040885. [DOI] [PubMed] [Google Scholar]
83.Marta CB, Montano MB, Taylor CM, Taylor AL, Bansal R, Pfeiffer SE. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. J Biol Chem. 2005;280:8985–8993. doi: 10.1074/jbc.M413174200. [DOI] [PubMed] [Google Scholar]
84.Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci. 2003;23:5461–5471. doi: 10.1523/JNEUROSCI.23-13-05461.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]
85.Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol. 2004;164:1673–1682. doi: 10.1016/S0002-9440(10)63726-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
86.Matthews AE, Weiss SR, Paterson Y. Murine hepatitis virus - a model for virus- induced CNS demyelination. J Neurovirol. 2002;8:76–85. doi: 10.1080/13550280290049534. [DOI] [PMC free article] [PubMed] [Google Scholar]
87.Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 1994;120:143–153. doi: 10.1242/dev.120.1.143. [DOI] [PubMed] [Google Scholar]
88.McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999;5:1410–1412. doi: 10.1038/70986. [DOI] [PubMed] [Google Scholar]
89.McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain. 2000;123:519–531. doi: 10.1093/brain/123.3.519. [DOI] [PMC free article] [PubMed] [Google Scholar]
90.McMorris FA, Dubois-Dalcq M. Insulin-like growth factor I promotes cell prolifera- tion and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res. 1988;21:199–209. doi: 10.1002/jnr.490210212. [DOI] [PubMed] [Google Scholar]
91.McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann N Y Acad Sci. 1993;692:321–334. doi: 10.1111/j.1749-6632.1993.tb26247.x. [DOI] [PubMed] [Google Scholar]
92.McTigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci. 1998;18:5354–5365. doi: 10.1523/JNEUROSCI.18-14-05354.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
93.Mews I, Bergmann M, Bunkowski S, Gullotta F, Bruck W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler. 1998;4:55–62. doi: 10.1177/135245859800400203. [DOI] [PubMed] [Google Scholar]
94.Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779–1782. doi: 10.1126/science.290.5497.1779. [DOI] [PubMed] [Google Scholar]
95.Mikami Y, Okano H, Sakaguchi M, Nakamura M, Shimazaki T, Okano HJ, Kawakami Y, Toyama Y, Toda M. Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. J Neurosci Res. 2004;76:453–465. doi: 10.1002/jnr.20086. [DOI] [PubMed] [Google Scholar]
96.Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer- Hulme AJ, Dalton CM, Miszkiel KA, O’Connor PW. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003;348:15–23. doi: 10.1056/NEJMoa020696. [DOI] [PubMed] [Google Scholar]
97.Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. Monoclonal autoantibodies pro- mote central nervous system repair in an animal model of multiple sclerosis. J Neurosci. 1994;14:6230–6238. doi: 10.1523/JNEUROSCI.14-10-06230.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]
98.Mitsunaga Y, Ciric B, Van Keulen V, Warrington AE, Paz Soldan M, Bieber AJ, Rodriguez M, Pease LR. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J. 2002;16:1325–1327. doi: 10.1096/fj.01-0994fje. [DOI] [PubMed] [Google Scholar]
99.Moalem G, Monsonego A, Shani Y, Cohen IR, Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 1999;13:1207–1217. doi: 10.1096/fasebj.13.10.1207. [DOI] [PubMed] [Google Scholar]
100.Muir DA, Compston DA. Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res. 1996;44:1–11. doi: 10.1002/(SICI)1097-4547(19960401)44:1<1::AID-JNR1>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]
101.Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol. 1998;72:7320–7329. doi: 10.1128/jvi.72.9.7320-7329.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
102.Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Van Evercooren AB. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci. 1999;11:4357–4366. doi: 10.1046/j.1460-9568.1999.00873.x. [DOI] [PubMed] [Google Scholar]
103.Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA. 2007;104:4694–4699. doi: 10.1073/pnas.0606835104. [DOI] [PMC free article] [PubMed] [Google Scholar]
104.Njenga MK, Murray PD, McGavern D, Lin X, Drescher KM, Rodriguez M. Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler’s virus. J Neuropathol Exp Neurol. 1999;58:78–91. doi: 10.1097/00005072-199901000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]
105.Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth fac- tor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/ type-2 astrocyte progenitor cell. Nature. 1988;333:560–562. doi: 10.1038/333560a0. [DOI] [PubMed] [Google Scholar]
106.Noseworthy JH, Gold R, Hartung HP. Treatment of multiple sclerosis: recent trials and future perspectives. Curr Opin Neurol. 1999;12:279–293. doi: 10.1097/00019052-199906000-00007. [DOI] [PubMed] [Google Scholar]
107.Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, 2nd, Jiang L, Kang J, Nedergaard M, Goldman SA. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003;9:439–447. doi: 10.1038/nm837. [DOI] [PubMed] [Google Scholar]
108.Pannu R, Christie DK, Barbosa E, Singh I, Singh AK. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. J Neurochem. 2007;101:182–200. doi: 10.1111/j.1471-4159.2006.04354.x. [DOI] [PubMed] [Google Scholar]
109.Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006;129:3165–3172. doi: 10.1093/brain/awl217. [DOI] [PubMed] [Google Scholar]
110.Pavelko KD, van Engelen BG, Rodriguez M. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci. 1998;18:2498–2505. doi: 10.1523/JNEUROSCI.18-07-02498.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
111.Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003;22:14–24. doi: 10.1016/S1044-7431(02)00018-0. [DOI] [PubMed] [Google Scholar]
112.Penderis J, Shields SA, Franklin RJ. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain. 2003;126:1382–1391. doi: 10.1093/brain/awg126. [DOI] [PubMed] [Google Scholar]
113.Perier O, Gregoire A. Electron microscopic features of multiple sclerosis lesions. Brain. 1965;88:937–952. doi: 10.1093/brain/88.5.937. [DOI] [PubMed] [Google Scholar]
114.Pirko I, Ciric B, Gamez J, Bieber AJ, Warrington AE, Johnson AJ, Hanson DP, Pease LR, Macura SI, Rodriguez M. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virusinduced murine model of MS. FASEB J. 2004;18:1577–1579. doi: 10.1096/fj.04-2026fje. [DOI] [PubMed] [Google Scholar]
115.Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R, Comi G, Vescovi AL, Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003;422:688–694. doi: 10.1038/nature01552. [DOI] [PubMed] [Google Scholar]
116.Prabhakar S, D’Souza S, Antel JP, McLaurin J, Schipper HM, Wang E. Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res. 1995;672:159–169. doi: 10.1016/0006-8993(94)01377-T. [DOI] [PubMed] [Google Scholar]
117.Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol. 1993;33:137–151. doi: 10.1002/ana.410330203. [DOI] [PubMed] [Google Scholar]
118.Prineas JW, Wright RG. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978;38:409–421. [PubMed] [Google Scholar]
119.Qian X, Davis AA, Goderie SK, Temple S. FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron. 1997;18:81–93. doi: 10.1016/S0896-6273(01)80048-9. [DOI] [PubMed] [Google Scholar]
120.Raine CS, Stone SH. Animal model for multiple sclerosis. Chronic experimental allergic encephalomyelitis in inbred guinea pigs. N Y State J Med. 1977;77:1693–1696. [PubMed] [Google Scholar]
121.Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 1998;4:814–821. doi: 10.1038/nm0798-814. [DOI] [PubMed] [Google Scholar]
122.Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 1991;252:1705–1758. doi: 10.1126/science.1646484. [DOI] [PubMed] [Google Scholar]
123.Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 1988;53:309–319. doi: 10.1016/0092-8674(88)90392-3. [DOI] [PubMed] [Google Scholar]
124.Riggott MJ, Matthew WD. Neurite outgrowth is enhanced by anti-idiotypic monoclonal antibodies to the ganglioside GM1. Exp Neurol. 1997;145:278–287. doi: 10.1006/exnr.1997.6459. [DOI] [PubMed] [Google Scholar]
125.Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med. 1998;4:187–193. doi: 10.1038/nm0298-187. [DOI] [PMC free article] [PubMed] [Google Scholar]
126.Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. The chemokine growthregulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci. 1998;18:10457–10563. doi: 10.1523/JNEUROSCI.18-24-10457.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]
127.Rodriguez M. Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest. 1991;64:358–370. [PubMed] [Google Scholar]
128.Rodriguez M. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. Brain. 2003;126:751–752. doi: 10.1093/brain/awg070. [DOI] [PubMed] [Google Scholar]
129.Rodriguez M. Effectors of demyelination and remyelination in the CNS: Implications for multiple sclerosis. Brain Pathol. 2007;17:219–229. doi: 10.1111/j.1750-3639.2007.00065.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
130.Rodriguez M, Karnes WE, Bartleson JD, Pineda AA. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 1993;43:1100–1104. doi: 10.1212/wnl.43.6.1100. [DOI] [PubMed] [Google Scholar]
131.Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol. 1990;27:12–17. doi: 10.1002/ana.410270104. [DOI] [PubMed] [Google Scholar]
132.Rodriguez M, Lennon VA, Benveniste EN, Merrill JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol. 1987;46:84–95. doi: 10.1097/00005072-198701000-00008. [DOI] [PubMed] [Google Scholar]
133.Rodriguez M, Miller DJ, Lennon VA. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology. 1996;46:538–545. doi: 10.1212/wnl.46.2.538. [DOI] [PubMed] [Google Scholar]
134.Rodriguez M, Oleszak E, Leibowitz J. Theiler’s murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol. 1987;7:325–365. [PubMed] [Google Scholar]
135.Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc. 1993;68:627–636. doi: 10.1016/s0025-6196(12)60597-7. [DOI] [PubMed] [Google Scholar]
136.Rubin BP, Dusart I, Schwab ME. A monoclonal antibody (IN-1) which neutralizes neurite growth inhibitory proteins in the rat CNS recognizes antigens localized in CNS myelin. J Neurocytol. 1994;23:209–217. doi: 10.1007/BF01275525. [DOI] [PubMed] [Google Scholar]
137.Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia. 2001;35:26–34. doi: 10.1002/glia.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]
138.Schluesener HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol. 1987;139:4016–4021. [PubMed] [Google Scholar]
139.Schwab ME. Structural plasticity of the adult CNS. Negative control by neurite growth inhibitory signals. Int J Dev Neurosci. 1996;14:379–385. doi: 10.1016/0736-5748(96)00024-X. [DOI] [PubMed] [Google Scholar]
140.Schwartz M, Moalem G, Leibowitz-Amit R, Cohen IR. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 1999;22:295–299. doi: 10.1016/S0166-2236(99)01405-8. [DOI] [PubMed] [Google Scholar]
141.Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, Franklin RJ. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia. 2006;54:297–303. doi: 10.1002/glia.20371. [DOI] [PubMed] [Google Scholar]
142.Sindic CJ, Cambiaso CL, Depre A, Laterre EC, Masson PL. The concentration of IgM in the cerebrospinal fluid of neurological patients. J Neurol Sci. 1982;55:339–350. doi: 10.1016/0022-510X(82)90131-9. [DOI] [PubMed] [Google Scholar]
143.Sindic CJ, Monteyne P, Laterre EC. Occurrence of oligoclonal IgM bands in the cerebrospinal fluid of neurological patients: an immunoaffinity-mediated capillary blot study. J Neurol Sci. 1994;124:215–219. doi: 10.1016/0022-510X(94)90329-8. [DOI] [PubMed] [Google Scholar]
144.Smith EJ, Blakemore WF, McDonald WI. Central remyelination restores secure conduction. Nature. 1979;280:395–396. doi: 10.1038/280395a0. [DOI] [PubMed] [Google Scholar]
145.Sommer I, Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol. 1981;83:311–327. doi: 10.1016/0012-1606(81)90477-2. [DOI] [PubMed] [Google Scholar]
146.Spirman N, Sela BA, Gitler C, Calef E, Schwartz M. Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly. J Neuroimmunol. 1984;6:197–207. doi: 10.1016/0165-5728(84)90006-7. [DOI] [PubMed] [Google Scholar]
147.Spirman N, Sela BA, Schwartz M. Antiganglioside antibodies inhibit neuritic outgrowth from regenerating goldfish retinal explants. J Neurochem. 1982;39:874–877. doi: 10.1111/j.1471-4159.1982.tb07974.x. [DOI] [PubMed] [Google Scholar]
148.Stohlman SA, Hinton DR. Viral induced demyelination. Brain Pathol. 2001;11:92–106. doi: 10.1111/j.1750-3639.2001.tb00384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
149.Suzuki K, Andrews JM, Waltz JM, Terry RD. Ultrastructural studies of multiple sclerosis. Lab Invest. 1969;20:444–454. [PubMed] [Google Scholar]
150.Teitelbaum D, Aharoni R, Sela M, Arnon R. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proc Natl Acad Sci U S A. 1991;88:9528–9532. doi: 10.1073/pnas.88.21.9528. [DOI] [PMC free article] [PubMed] [Google Scholar]
151.Totoiu MO, Nistor GI, Lane TE, Keirstead HS. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol. 2004;187:254–265. doi: 10.1016/j.expneurol.2004.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]
152.Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–285. doi: 10.1056/NEJM199801293380502. [DOI] [PubMed] [Google Scholar]
153.Tripathi R, McTigue DM. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia. 2007;55:698–711. doi: 10.1002/glia.20491. [DOI] [PubMed] [Google Scholar]
154.Ure DR, Rodriguez M. Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. FASEB J. 2002;16:1260–1262. doi: 10.1096/fj.01-1023fje. [DOI] [PubMed] [Google Scholar]
155.Ure DR, Rodriguez M. Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis. Neuroscience. 2002;111:399–411. doi: 10.1016/S0306-4522(02)00012-X. [DOI] [PubMed] [Google Scholar]
156.Utzschneider DA, Archer DR, Kocsis JD, Waxman SG, Duncan ID. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc Natl Acad Sci U S A. 1994;91:53–57. doi: 10.1073/pnas.91.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
157.Vartanian T, Fischbach G, Miller R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci U S A. 1999;96:731–735. doi: 10.1073/pnas.96.2.731. [DOI] [PMC free article] [PubMed] [Google Scholar]
158.Vieira P, Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol. 1988;18:313–316. doi: 10.1002/eji.1830180221. [DOI] [PubMed] [Google Scholar]
159.Vincent A, Lily O, Palace J. Pathogenic autoantibodies to neuronal proteins in neurological disorders. J Neuroimmunol. 1999;100:169–180. doi: 10.1016/S0165-5728(99)00210-6. [DOI] [PubMed] [Google Scholar]
160.Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A. 2002;99:8412–8417. doi: 10.1073/pnas.072211699. [DOI] [PMC free article] [PubMed] [Google Scholar]
161.Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA. 2000;97:6820–6825. doi: 10.1073/pnas.97.12.6820. [DOI] [PMC free article] [PubMed] [Google Scholar]
162.Warrington AE, Barbarese E, Pfeiffer SE. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res. 1993;34:1–13. doi: 10.1002/jnr.490340102. [DOI] [PubMed] [Google Scholar]
163.Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res. 2007;85:967–976. doi: 10.1002/jnr.21217. [DOI] [PubMed] [Google Scholar]
164.Warrington AE, Bieber AJ, Van Keulen V, Ciric B, Pease LR, Rodriguez M. Neuronbinding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol. 2004;63:461–473. doi: 10.1093/jnen/63.5.461. [DOI] [PubMed] [Google Scholar]
165.Warrington AE, Pfeiffer SE. Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: analysis in unfixed tissue slices using anti-glycolipid antibodies. J Neurosci Res. 1992;33:338–353. doi: 10.1002/jnr.490330218. [DOI] [PubMed] [Google Scholar]
166.Weibel D, Cadelli D, Schwab ME. Regeneration of lesioned rat optic nerve fibers is improved after neutralization of myelin-associated neurite growth inhibitors. Brain Res. 1994;642:259–266. doi: 10.1016/0006-8993(94)90930-X. [DOI] [PubMed] [Google Scholar]
167.Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878–886. doi: 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]
168.Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMOIgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006;22:197–206. doi: 10.1155/2006/586306. [DOI] [PMC free article] [PubMed] [Google Scholar]
169.Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G, 2nd, Roy NS, Goldman SA. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med. 2004;10:93–97. doi: 10.1038/nm974. [DOI] [PubMed] [Google Scholar]
170.Wolswijk G. Oligodendrocyte precursor cells in chronic multiple sclerosis lesions. Mult Scler. 1997;3:168–169. doi: 10.1177/135245859700300221. [DOI] [PubMed] [Google Scholar]
171.Woodruff RH, Franklin RJ. Growth factors and remyelination in the CNS. Histol Histopathol. 1997;12:459–466. [PubMed] [Google Scholar]
172.Yajima K, Suzuki K. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest. 1979;41:385–392. [PubMed] [Google Scholar]
173.Yandava BD, Billinghurst LL, Snyder EY. “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci U S A. 1999;96:7029–7034. doi: 10.1073/pnas.96.12.7029. [DOI] [PMC free article] [PubMed] [Google Scholar]
174.Yao DL, Liu X, Hudson LD, Webster HD. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 1995;92:6190–194. doi: 10.1073/pnas.92.13.6190. [DOI] [PMC free article] [PubMed] [Google Scholar]
175.Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A, Kuchroo V, Cohen IR, Weiner H, Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001;21:3740–3748. doi: 10.1523/JNEUROSCI.21-11-03740.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]
176.Ziemssen T, Ziemssen F. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) Autoimmun Rev. 2005;4:460–467. doi: 10.1016/j.autrev.2005.03.005. [DOI] [PubMed] [Google Scholar]

[CR1_Ref] 1.Aarum J, Sandberg K, Haeberlein SL, Persson MA. Migration and differentiation of neural precursor cells can be directed by microglia. Proc Natl Acad Sci USA. 2003;100:15983–15988. doi: 10.1073/pnas.2237050100. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR2_Ref] 2.Akiyama Y, Radtke C, Honmou O, Kocsis JD. Remyelination of the spinal cord following intravenous delivery of bone marrow cells. Glia. 2002;39:229–236. doi: 10.1002/glia.10102. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR3_Ref] 3.Akiyama Y, Radtke C, Kocsis JD. Remyelination of the rat spinal cord by transplantation of identified bone marrow stromal cells. J Neurosci. 2002;22:6623–6630. doi: 10.1523/JNEUROSCI.22-15-06623.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR4_Ref] 4.Almazan G, Honegger P, Matthieu JM. Triiodothyronine stimulation of oligodendroglial differentiation and myelination. A developmental study. Dev Neurosci. 1985;7:45–54. doi: 10.1159/000112275. [DOI] [PubMed] [Google Scholar]

[CR5_Ref] 5.Annunziata P, Pluchino S, Martino T, Guazzi G. High levels of cerebrospinal fluid IgM binding to myelin basic protein are associated with early benign course in multiple sclerosis. J Neuroimmunol. 1997;77:128–133. doi: 10.1016/S0165-5728(97)00074-X. [DOI] [PubMed] [Google Scholar]

[CR6_Ref] 6.Armstrong RC, Dorn HH, Kufta CV, Friedman E, Dubois-Dalcq ME. Pre-oligodendrocytes from adult human CNS. J Neurosci. 1992;12:1538–1547. doi: 10.1523/JNEUROSCI.12-04-01538.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR7_Ref] 7.Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci . 2001;4:1116–1122. doi: 10.1038/nn738. [DOI] [PubMed] [Google Scholar]

[CR8_Ref] 8.Asakura K, Miller DJ, Murray K, Bansal R, Pfeiffer SE, Rodriguez M. Monoclonal autoantibody SCH94.03, which promotes central nervous system remyelination, recognizes an antigen on the surface of oligodendrocytes. J Neurosci Res. 1996;43:273–281. doi: 10.1002/(SICI)1097-4547(19960201)43:3<273::AID-JNR2>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]

[CR9_Ref] 9.Asakura K, Miller DJ, Pease LR, Rodriguez M. Targeting of IgM kappa antibodies to oligodendrocytes promotes CNS remyelination. J Neurosci. 1998;18:7700–7708. doi: 10.1523/JNEUROSCI.18-19-07700.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR10_Ref] 10.Bansal R. Fibroblast growth factors and their receptors in oligodendrocyte development: implications for demyelination and remyelination. Dev Neurosci. 2002;24:35–46. doi: 10.1159/000064944. [DOI] [PubMed] [Google Scholar]

[CR11_Ref] 11.Bansal R, Winkler S, Bheddah S. Negative regulation of oligodendrocyte differentiation by galactosphingolipids. J Neurosci. 1999;19:7913–7924. doi: 10.1523/JNEUROSCI.19-18-07913.1999. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR12_Ref] 12.Barouch R, Schwartz M. Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity. FASEB J. 2002;16:1304–1306. doi: 10.1096/fj.01-0467fje. [DOI] [PubMed] [Google Scholar]

[CR13_Ref] 13.Barres BA, Lazar MA, Raff MC. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development. 1994;120:1097–1108. doi: 10.1242/dev.120.5.1097. [DOI] [PubMed] [Google Scholar]

[CR14_Ref] 14.Barres BA, Schmid R, Sendnter M, Raff MC. Multiple extracellular signals are required for long-term oligodendrocyte survival. Development. 1993;118:283–295. doi: 10.1242/dev.118.1.283. [DOI] [PubMed] [Google Scholar]

[CR15_Ref] 15.Ben-Hur T, Einstein O, Mizrachi-Kol R, Ben-Menachem O, Reinhartz E, Karussis D, Abramsky O. Transplanted multipotential neural precursor cells migrate into the inflamed white matter in response to experimental autoimmune encephalomyelitis. Glia. 2003;41:73–80. doi: 10.1002/glia.10159. [DOI] [PubMed] [Google Scholar]

[CR16_Ref] 16.Bieber AJ, Kerr S, Rodriguez M. Efficient central nervous system remyelination requires T cells. Ann Neurol. 2003;53:680–684. doi: 10.1002/ana.10578. [DOI] [PubMed] [Google Scholar]

[CR17_Ref] 17.Bieber AJ, Ure DR, Rodriguez M. Genetically dominant spinal cord repair in a murine model of chronic progressive multiple sclerosis. J Neuropathol Exp Neurol. 2005;64:46–57. doi: 10.1093/jnen/64.1.46. [DOI] [PubMed] [Google Scholar]

[CR18_Ref] 18.Bieber AJ, Warrington A, Asakura K, Ciric B, Kaveri SV, Pease LR, Rodriguez M. Human antibodies accelerate the rate of remyelination following lysolecithin-induced demyelination in mice. Glia. 2002;37:241–249. doi: 10.1002/glia.10033. [DOI] [PubMed] [Google Scholar]

[CR19_Ref] 19.Bieber AJ, Warrington A, Pease LR, Rodriguez M. Humoral autoimmunity as a mediator of CNS repair. Trends Neurosci. 2001;24:S39–S44. doi: 10.1016/S0166-2236(00)01991-3. [DOI] [PubMed] [Google Scholar]

[CR20_Ref] 20.Bjartmar C, Trapp BD. Axonal and neuronal degeneration in multiple sclerosis: mechanisms and functional consequences. Curr Opin Neurol. 2001;14:271–278. doi: 10.1097/00019052-200106000-00003. [DOI] [PubMed] [Google Scholar]

[CR21_Ref] 21.Blakemore WF. Demyelination of the superior cerebellar peduncle in the mouse induced by cuprizone. J Neurol Sci. 1973;20:63–72. doi: 10.1016/0022-510X(73)90118-4. [DOI] [PubMed] [Google Scholar]

[CR22_Ref] 22.Blakemore WF, Crang AJ. Extensive oligodendrocyte remyelination following injection of cultured central nervous system cells into demyelinating lesions in adult central nervous system. Dev Neurosci. 1988;10:1–11. doi: 10.1159/000111949. [DOI] [PubMed] [Google Scholar]

[CR23_Ref] 23.Bogler O, Wren D, Barnett SC, Land H, Noble M. Cooperation between two growth factors promotes extended self-renewal and inhibits differentiation of oligodendrocyte-type- 2 astrocyte (O-2A) progenitor cells. Proc Natl Acad Sci U S A. 1990;87:6368–6372. doi: 10.1073/pnas.87.16.6368. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR24_Ref] 24.Bregman BS, Kunkel-Bagden E, Schnell L, Dai HN, Gao D, Schwab ME. Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature. 1995;378:498–501. doi: 10.1038/378498a0. [DOI] [PubMed] [Google Scholar]

[CR25_Ref] 25.Brenner T, Arnon R, Sela M, Abramsky O, Meiner Z, Riven-Kreitman R, Tarcik N, Teitelbaum D. Humoral and cellular immune responses to Copolymer 1 in multiple sclerosis patients treated with Copaxone. J Neuroimmunol. 2001;115:152–160. doi: 10.1016/S0165-5728(01)00250-8. [DOI] [PubMed] [Google Scholar]

[CR26_Ref] 26.Bruck W, Kuhlmann T, Stadelmann C. Remyelination in multiple sclerosis. J Neurol Sci. 2003;206:181–185. doi: 10.1016/S0022-510X(02)00191-0. [DOI] [PubMed] [Google Scholar]

[CR27_Ref] 27.Brustle O, Jones KN, Learish RD, Karram K, Choudhary K, Wiestler OD, Duncan ID, McKay RD. Embryonic stem cell-derived glial precursors: a source of myelinating transplants. Science. 1999;285:754–756. doi: 10.1126/science.285.5428.754. [DOI] [PubMed] [Google Scholar]

[CR28_Ref] 28.Caroni P, Schwab ME. Antibody against myelin-associated inhibitor of neurite growth neutralizes nonpermissive substrate properties of CNS white matter. Neuron. 1988;1:85–96. doi: 10.1016/0896-6273(88)90212-7. [DOI] [PubMed] [Google Scholar]

[CR29_Ref] 29.Chang A, Nishiyama A, Peterson J, Prineas J, Trapp BD. NG2-positive oligodendrocyte progenitor cells in adult human brain and multiple sclerosis lesions. J Neurosci. 2000;20:6404–6412. doi: 10.1523/JNEUROSCI.20-17-06404.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR30_Ref] 30.Chang A, Tourtellotte WW, Rudick R, Trapp BD. Premyelinating oligodendrocytes in chronic lesions of multiple sclerosis. N Engl J Med. 2002;346:165–173. doi: 10.1056/NEJMoa010994. [DOI] [PubMed] [Google Scholar]

[CR31_Ref] 31.Chen MS, Huber AB, van der Haar ME, Frank M, Schnell L, Spillmann AA, Christ F, Schwab ME. Nogo-A is a myelin-associated neurite outgrowth inhibitor and an antigen for monoclonal antibody IN-1. Nature. 2000;403:434–439. doi: 10.1038/35000601. [DOI] [PubMed] [Google Scholar]

[CR32_Ref] 32.Ciric B, Howe CL, Paz Soldan M, Warrington AE, Bieber AJ, Van Keulen V, Rodriguez M, Pease LR. Human monoclonal IgM antibody promotes CNS myelin repair independent of Fc function. Brain Pathol. 2003;13:608–616. doi: 10.1111/j.1750-3639.2003.tb00489.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR33_Ref] 33.Ciric B, VanKeulen V, Rodriguez M, Kyle RA, Gertz MA, Pease LR. Clonal evolution in Waldenstrom macroglobulinemia highlights functional role of B-cell receptor. Blood. 2001;97:321–323. doi: 10.1182/blood.V97.1.321. [DOI] [PubMed] [Google Scholar]

[CR34_Ref] 34.Cohen IR, Schwartz M. Autoimmune maintenance and neuroprotection of the central nervous system. J Neuroimmunol. 1999;100:111–114. doi: 10.1016/S0165-5728(99)00190-3. [DOI] [PubMed] [Google Scholar]

[CR35_Ref] 35.Dal Canto MC, Lipton HL. Multiple sclerosis. Animal model: Theiler’s virus infection in mice. Am J Pathol. 1977;88:497–500. [PMC free article] [PubMed] [Google Scholar]

[CR36_Ref] 36.Dodel R, Hampel H, Depboylu C, Lin S, Gao F, Schock S, Jackel S, Wei X, Buerger K, Hoft C, Hemmer B, Moller HJ, Farlow M, Oertel WH, Sommer N, Du Y. Human antibodies against amyloid beta peptide: a potential treatment for Alzheimer’s disease. Ann Neurol. 2002;52:253–256. doi: 10.1002/ana.10253. [DOI] [PubMed] [Google Scholar]

[CR37_Ref] 37.Duncan ID. Glial cell transplantation and remyelination of the central nervous system. Neuropathol Appl Neurobiol. 1996;22:87–100. doi: 10.1111/j.1365-2990.1996.tb00852.x. [DOI] [PubMed] [Google Scholar]

[CR38_Ref] 38.Dyer CA. Novel oligodendrocyte transmembrane signaling systems. Investigations utilizing antibodies as ligands. Mol Neurobiol. 1993;7:1–22. doi: 10.1007/BF02780606. [DOI] [PubMed] [Google Scholar]

[CR39_Ref] 39.Dyer CA, Benjamins JA. Redistribution and internalization of antibodies to galactocerebroside by oligodendroglia. J Neurosci. 1988;8:883–891. doi: 10.1523/JNEUROSCI.08-03-00883.1988. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR40_Ref] 40.Einstein O, Karussis D, Grigoriadis N, Mizrachi-Kol R, Reinhartz E, Abramsky O, Ben-Hur T. Intraventricular transplantation of neural precursor cell spheres attenuates acute experimental allergic encephalomyelitis. Mol Cell Neurosci. 2003;24:1074–1082. doi: 10.1016/j.mcn.2003.08.009. [DOI] [PubMed] [Google Scholar]

[CR41_Ref] 41.Ellezam B, Bertrand J, Dergham P, McKerracher L. Vaccination stimulates retinal ganglion cell regeneration in the adult optic nerve. Neurobiol Dis. 2003;12:1–10. doi: 10.1016/S0969-9961(02)00013-X. [DOI] [PubMed] [Google Scholar]

[CR42_Ref] 42.Feigin I, Popoff N. Regeneration of myelin in multiple sclerosis. The role of mesenchymal cells in such regeneration and in myelin formation in the peripheral nervous system. Neurology. 1966;16:364–372. doi: 10.1212/wnl.16.4.364. [DOI] [PubMed] [Google Scholar]

[CR43_Ref] 43.Fernandez M, Giuliani A, Pirondi S, D’Intino G, Giardino L, Aloe L, Levi-Montalcini R, Calza L. Thyroid hormone administration enhances remyelination in chronic demyelinating inflammatory disease. Proc Natl Acad Sci U S A. 2004;101:16363–16368. doi: 10.1073/pnas.0407262101. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR44_Ref] 44.Franklin RJ. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci. 2002;3:705–714. doi: 10.1038/nrn917. [DOI] [PubMed] [Google Scholar]

[CR45_Ref] 45.Franklin RJ, Gilson JM, Blakemore WF. Local recruitment of remyelinating cells in the repair of demyelination in the central nervous system. J Neurosci Res. 1997;50:337–344. doi: 10.1002/(SICI)1097-4547(19971015)50:2<337::AID-JNR21>3.0.CO;2-3. [DOI] [PubMed] [Google Scholar]

[CR46_Ref] 46.Franklin RJ, Hinks GL, Woodruff RH, O’Leary MT. What roles do growth factors play in CNS remyelination? Prog Brain Res. 2001;132:185–193. doi: 10.1016/S0079-6123(01)32075-7. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR47_Ref] 47.Gaiano N, Fishell G. Transplantation as a tool to study progenitors within the vertebrate nervous system. J Neurobiol. 1998;36:152–161. doi: 10.1002/(SICI)1097-4695(199808)36:2<152::AID-NEU4>3.0.CO;2-0. [DOI] [PubMed] [Google Scholar]

[CR48_Ref] 48.Goddard DR, Berry M, Butt AM. In vivo actions of fibroblast growth factor-2 and insulin-like growth factor-I on oligodendrocyte development and myelination in the central nervous system. J Neurosci Res. 1999;57:74–85. doi: 10.1002/(SICI)1097-4547(19990701)57:1<74::AID-JNR8>3.0.CO;2-O. [DOI] [PubMed] [Google Scholar]

[CR49_Ref] 49.GrandPre T, Nakamura F, Vartanian T, Strittmatter SM. Identification of the Nogo inhibitor of axon regeneration as a Reticulon protein. Nature. 2000;403:439–444. doi: 10.1038/35000226. [DOI] [PubMed] [Google Scholar]

[CR50_Ref] 50.Guimond SE, Turnbull JE. Fibroblast growth factor receptor signalling is dictated by specific heparan sulphate saccharides. Curr Biol. 1999;9:1343–1346. doi: 10.1016/S0960-9822(00)80060-3. [DOI] [PubMed] [Google Scholar]

[CR51_Ref] 51.Hall SM. The effect of injections of lysophosphatidyl choline into white matter of the adult mouse spinal cord. J Cell Sci. 1972;10:535–546. doi: 10.1242/jcs.10.2.535. [DOI] [PubMed] [Google Scholar]

[CR52_Ref] 52.Hammarberg H, Lidman O, Lundberg C, Eltayeb SY, Gielen AW, Muhallab S, Svenningsson A, Linda H, van Der Meide PH, Cullheim S, Olsson T, Piehl F. Neuroprotection by encephalomyelitis: rescue of mechanically injured neurons and neurotrophin production by CNS-infiltrating T and natural killer cells. J Neurosci. 2000;20:5283–5291. doi: 10.1523/JNEUROSCI.20-14-05283.2000. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR53_Ref] 53.Herndon RM, Price DL, Weiner LP. Regeneration of oligodendroglia during recovery from demyelinating disease. Science. 1977;195:693–694. doi: 10.1126/science.190678. [DOI] [PubMed] [Google Scholar]

[CR54_Ref] 54.Hohlfeld R, Kerschensteiner M, Stadelmann C, Lassmann H, Wekerle H. The neuro- protective effect of inflammation: implications for the therapy of multiple sclerosis. J Neuroimmunol. 2000;107:161–166. doi: 10.1016/S0165-5728(00)00233-2. [DOI] [PubMed] [Google Scholar]

[CR55_Ref] 55.Howe CL, Bieber AJ, Warrington AE, Pease LR, Rodriguez M. Antiapoptotic signal- ing by a remyelination-promoting human antimyelin antibody. Neurobiol Dis. 2004;15:120–131. doi: 10.1016/j.nbd.2003.09.002. [DOI] [PubMed] [Google Scholar]

[CR56_Ref] 56.Howe CL, Mayoral S, Rodriguez M. Activated microglia stimulate transcriptional changes in primary oligodendrocytes via IL-1beta. Neurobiol Dis. 2006;23:731–739. doi: 10.1016/j.nbd.2006.06.012. [DOI] [PubMed] [Google Scholar]

[CR57_Ref] 57.Huang DW, McKerracher L, Braun PE, David S. A therapeutic vaccine approach to stimulate axon regeneration in the adult mammalian spinal cord. Neuron. 1999;24:639–647. doi: 10.1016/S0896-6273(00)81118-6. [DOI] [PubMed] [Google Scholar]

[CR58_Ref] 58.Hunter SF, Miller DJ, Rodriguez M. Monoclonal remyelination-promoting natural autoantibody SCH 94.03: pharmacokinetics and in vivo targets within demyelinated spinal cord in a mouse model of multiple sclerosis. J Neurol Sci. 1997;150:103–113. doi: 10.1016/S0022-510X(97)00080-4. [DOI] [PubMed] [Google Scholar]

[CR59_Ref] 59.Imitola J, Comabella M, Chandraker AK, Dangond F, Sayegh MH, Snyder EY, Khoury SJ. Neural stem/progenitor cells express costimulatory molecules that are differentially regulated by inflammatory and apoptotic stimuli. Am J Pathol. 2004;164:1615–1625. doi: 10.1016/S0002-9440(10)63720-0. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR60_Ref] 60.Jeffery ND, Blakemore WF. Remyelination of mouse spinal cord axons demyelinated by local injection of lysolecithin. J Neurocytol. 1995;24:775–781. doi: 10.1007/BF01191213. [DOI] [PubMed] [Google Scholar]

[CR61_Ref] 61.Jeffery ND, Blakemore WF. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain. 1997;120:27–37. doi: 10.1093/brain/120.1.27. [DOI] [PubMed] [Google Scholar]

[CR62_Ref] 62.Jeffery ND, Crang AJ, O’Leary M T, Hodge SJ, Blakemore WF. Behavioural conse- quences of oligodendrocyte progenitor cell transplantation into experimental demyelinating lesions in the rat spinal cord. Eur J Neurosci. 1999;11:1508–1514. doi: 10.1046/j.1460-9568.1999.00564.x. [DOI] [PubMed] [Google Scholar]

[CR63_Ref] 63.Johnson KP, Brooks BR, Cohen JA, Ford CC, Goldstein J, Lisak RP, Myers LW, Panitch HS, Rose JW, Schiffer RB. Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind pla- cebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group. Neurology. 1995;45:1268–1276. doi: 10.1212/wnl.45.7.1268. [DOI] [PubMed] [Google Scholar]

[CR64_Ref] 64.Johnson KP, Brooks BR, Ford CC, Goodman A, Guarnaccia J, Lisak RP, Myers LW, Panitch HS, Pruitt A, Rose JW, Kachuck N, Wolinsky JS. Sustained clinical benefits of glati- ramer acetate in relapsing multiple sclerosis patients observed for 6 years. Copolymer 1 Multiple Sclerosis Study Group. Mult Scler. 2000;6:255–266. doi: 10.1177/135245850000600407. [DOI] [PubMed] [Google Scholar]

[CR65_Ref] 65.Jones TB, Basso DM, Sodhi A, Pan JZ, Hart RP, MacCallum RC, Lee S, Whitacre CC, Popovich PG. Pathological CNS autoimmune disease triggered by traumatic spinal cord injury: implications for autoimmune vaccine therapy. J Neurosci. 2002;22:2690–2700. doi: 10.1523/JNEUROSCI.22-07-02690.2002. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR66_Ref] 66.Kasahara K, Watanabe K, Takeuchi K, Kaneko H, Oohira A, Yamamoto T, Sanai Y. Involvement of gangliosides in glycosylphosphatidylinositol-anchored neuronal cell adhe- sion molecule TAG-1 signaling in lipid rafts. J Biol Chem. 2000;275:34701–34709. doi: 10.1074/jbc.M003163200. [DOI] [PubMed] [Google Scholar]

[CR67_Ref] 67.Kasahara K, Watanabe Y, Yamamoto T, Sanai Y. Association of Src family tyrosine kinase Lyn with ganglioside GD3 in rat brain. Possible regulation of Lyn by glycosphingoli- pid in caveolae-like domains. J Biol Chem. 1997;272:29947–29953. doi: 10.1074/jbc.272.47.29947. [DOI] [PubMed] [Google Scholar]

[CR68_Ref] 68.Keegan BM, Noseworthy JH. Multiple sclerosis. Annu Rev Med. 2002;53:285–302. doi: 10.1146/annurev.med.53.082901.103909. [DOI] [PubMed] [Google Scholar]

[CR69_Ref] 69.Keegan M, Konig F, McClelland R, Bruck W, Morales Y, Bitsch A, Panitch H, Lassmann H, Weinshenker B, Rodriguez M, Parisi J, Lucchinetti CF. Relation between humoral pathologi- cal changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet. 2005;366:579–582. doi: 10.1016/S0140-6736(05)67102-4. [DOI] [PubMed] [Google Scholar]

[CR70_Ref] 70.Keirstead HS, Blakemore WF. The role of oligodendrocytes and oligodendrocyte pro- genitors in CNS remyelination. Adv Exp Med Biol. 1999;468:183–197. doi: 10.1007/978-1-4615-4685-6_15. [DOI] [PubMed] [Google Scholar]

[CR71_Ref] 71.Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, Misgeld T, Klinkert WE, Kolbeck R, Hoppe E, Oropeza-Wekerle RL, Bartke I, Stadelmann C, Lassmann H, Wekerle H, Hohlfeld R. Activated human T cells, B cells, and monocytes produce brain-derived neuro- trophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflamma- tion. J Exp Med. 1999;189:865–870. doi: 10.1084/jem.189.5.865. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR72_Ref] 72.Khalili K, White MK, Lublin F, Ferrante P, Berger JR. Reactivation of JC virus and development of PML in patients with multiple sclerosis. Neurology. 2007;68:985–990. doi: 10.1212/01.wnl.0000257832.38943.2b. [DOI] [PubMed] [Google Scholar]

[CR73_Ref] 73.Kohama I, Lankford KL, Preiningerova J, White FA, Vollmer TL, Kocsis JD. Transplantation of cryopreserved adult human Schwann cells enhances axonal conduction in demyelinated spinal cord. J Neurosci. 2001;21:944–950. doi: 10.1523/JNEUROSCI.21-03-00944.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR74_Ref] 74.Koshizuka S, Okada S, Okawa A, Koda M, Murasawa M, Hashimoto M, Kamada T, Yoshinaga K, Murakami M, Moriya H, Yamazaki M. Transplanted hematopoietic stem cells from bone marrow differentiate into neural lineage cells and promote functional recovery after spinal cord injury in mice. J Neuropathol Exp Neurol. 2004;63:64–72. doi: 10.1093/jnen/63.1.64. [DOI] [PubMed] [Google Scholar]

[CR75_Ref] 75.Kotter MR, Setzu A, Sim FJ, Rooijen N Van, Franklin RJ. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia. 2001;35:204–212. doi: 10.1002/glia.1085. [DOI] [PubMed] [Google Scholar]

[CR76_Ref] 76.Lennon VA, Wingerchuk DM, Kryzer TJ, Pittock SJ, Lucchinetti CF, Fujihara K, Nakashima I, Weinshenker BG. A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis. Lancet. 2004;364:2106–2112. doi: 10.1016/S0140-6736(04)17551-X. [DOI] [PubMed] [Google Scholar]

[CR77_Ref] 77.Lisak RP, Zweiman B, Blanchard N, Rorke LB. Effect of treatment with Copolymer 1 (Cop-1) on the in vivo and in vitro manifestations of experimental allergic encephalomy- elitis (EAE) J Neurol Sci. 1983;62:281–293. doi: 10.1016/0022-510X(83)90205-8. [DOI] [PubMed] [Google Scholar]

[CR78_Ref] 78.Liu S, Qu Y, Stewart TJ, Howard MJ, Chakrabortty S, Holekamp TF, McDonald JW. Embryonic stem cells differentiate into oligodendrocytes and myelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A. 2000;97:6126–6131. doi: 10.1073/pnas.97.11.6126. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR79_Ref] 79.Lucchinetti C, Bruck W. The pathology of primary progressive multiple sclerosis. Mult Scler. 2004;10([Suppl 1]):S23–S30. doi: 10.1177/135245850401000105. [DOI] [PubMed] [Google Scholar]

[CR80_Ref] 80.Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. A quan- titative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases. Brain. 1999;122:2279–2295. doi: 10.1093/brain/122.12.2279. [DOI] [PubMed] [Google Scholar]

[CR81_Ref] 81.Lucchinetti C, Bruck W, Parisi J, Scheithauer B, Rodriguez M, Lassmann H. Heterogeneity of multiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol. 2000;47:707–717. doi: 10.1002/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]

[CR82_Ref] 82.Lucchinetti CF, Brueck W, Rodriguez M, Lassmann H. Multiple sclerosis: lessons from neuropathology. Semin Neurol. 1998;18:337–349. doi: 10.1055/s-2008-1040885. [DOI] [PubMed] [Google Scholar]

[CR83_Ref] 83.Marta CB, Montano MB, Taylor CM, Taylor AL, Bansal R, Pfeiffer SE. Signaling cascades activated upon antibody cross-linking of myelin oligodendrocyte glycoprotein: potential implications for multiple sclerosis. J Biol Chem. 2005;280:8985–8993. doi: 10.1074/jbc.M413174200. [DOI] [PubMed] [Google Scholar]

[CR84_Ref] 84.Marta CB, Taylor CM, Coetzee T, Kim T, Winkler S, Bansal R, Pfeiffer SE. Antibody cross-linking of myelin oligodendrocyte glycoprotein leads to its rapid repartitioning into detergent-insoluble fractions, and altered protein phosphorylation and cell morphology. J Neurosci. 2003;23:5461–5471. doi: 10.1523/JNEUROSCI.23-13-05461.2003. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR85_Ref] 85.Mason JL, Toews A, Hostettler JD, Morell P, Suzuki K, Goldman JE, Matsushima GK. Oligodendrocytes and progenitors become progressively depleted within chronically demyelinated lesions. Am J Pathol. 2004;164:1673–1682. doi: 10.1016/S0002-9440(10)63726-1. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR86_Ref] 86.Matthews AE, Weiss SR, Paterson Y. Murine hepatitis virus - a model for virus- induced CNS demyelination. J Neurovirol. 2002;8:76–85. doi: 10.1080/13550280290049534. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR87_Ref] 87.Mayer M, Bhakoo K, Noble M. Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development. 1994;120:143–153. doi: 10.1242/dev.120.1.143. [DOI] [PubMed] [Google Scholar]

[CR88_Ref] 88.McDonald JW, Liu XZ, Qu Y, Liu S, Mickey SK, Turetsky D, Gottlieb DI, Choi DW. Transplanted embryonic stem cells survive, differentiate and promote recovery in injured rat spinal cord. Nat Med. 1999;5:1410–1412. doi: 10.1038/70986. [DOI] [PubMed] [Google Scholar]

[CR89_Ref] 89.McGavern DB, Murray PD, Rivera-Quinones C, Schmelzer JD, Low PA, Rodriguez M. Axonal loss results in spinal cord atrophy, electrophysiological abnormalities and neurological deficits following demyelination in a chronic inflammatory model of multiple sclerosis. Brain. 2000;123:519–531. doi: 10.1093/brain/123.3.519. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR90_Ref] 90.McMorris FA, Dubois-Dalcq M. Insulin-like growth factor I promotes cell prolifera- tion and oligodendroglial commitment in rat glial progenitor cells developing in vitro. J Neurosci Res. 1988;21:199–209. doi: 10.1002/jnr.490210212. [DOI] [PubMed] [Google Scholar]

[CR91_Ref] 91.McMorris FA, Mozell RL, Carson MJ, Shinar Y, Meyer RD, Marchetti N. Regulation of oligodendrocyte development and central nervous system myelination by insulin-like growth factors. Ann N Y Acad Sci. 1993;692:321–334. doi: 10.1111/j.1749-6632.1993.tb26247.x. [DOI] [PubMed] [Google Scholar]

[CR92_Ref] 92.McTigue DM, Horner PJ, Stokes BT, Gage FH. Neurotrophin-3 and brain-derived neurotrophic factor induce oligodendrocyte proliferation and myelination of regenerating axons in the contused adult rat spinal cord. J Neurosci. 1998;18:5354–5365. doi: 10.1523/JNEUROSCI.18-14-05354.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR93_Ref] 93.Mews I, Bergmann M, Bunkowski S, Gullotta F, Bruck W. Oligodendrocyte and axon pathology in clinically silent multiple sclerosis lesions. Mult Scler. 1998;4:55–62. doi: 10.1177/135245859800400203. [DOI] [PubMed] [Google Scholar]

[CR94_Ref] 94.Mezey E, Chandross KJ, Harta G, Maki RA, McKercher SR. Turning blood into brain: cells bearing neuronal antigens generated in vivo from bone marrow. Science. 2000;290:1779–1782. doi: 10.1126/science.290.5497.1779. [DOI] [PubMed] [Google Scholar]

[CR95_Ref] 95.Mikami Y, Okano H, Sakaguchi M, Nakamura M, Shimazaki T, Okano HJ, Kawakami Y, Toyama Y, Toda M. Implantation of dendritic cells in injured adult spinal cord results in activation of endogenous neural stem/progenitor cells leading to de novo neurogenesis and functional recovery. J Neurosci Res. 2004;76:453–465. doi: 10.1002/jnr.20086. [DOI] [PubMed] [Google Scholar]

[CR96_Ref] 96.Miller DH, Khan OA, Sheremata WA, Blumhardt LD, Rice GP, Libonati MA, Willmer- Hulme AJ, Dalton CM, Miszkiel KA, O’Connor PW. A controlled trial of natalizumab for relapsing multiple sclerosis. N Engl J Med. 2003;348:15–23. doi: 10.1056/NEJMoa020696. [DOI] [PubMed] [Google Scholar]

[CR97_Ref] 97.Miller DJ, Sanborn KS, Katzmann JA, Rodriguez M. Monoclonal autoantibodies pro- mote central nervous system repair in an animal model of multiple sclerosis. J Neurosci. 1994;14:6230–6238. doi: 10.1523/JNEUROSCI.14-10-06230.1994. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR98_Ref] 98.Mitsunaga Y, Ciric B, Van Keulen V, Warrington AE, Paz Soldan M, Bieber AJ, Rodriguez M, Pease LR. Direct evidence that a human antibody derived from patient serum can promote myelin repair in a mouse model of chronic-progressive demyelinating disease. FASEB J. 2002;16:1325–1327. doi: 10.1096/fj.01-0994fje. [DOI] [PubMed] [Google Scholar]

[CR99_Ref] 99.Moalem G, Monsonego A, Shani Y, Cohen IR, Schwartz M. Differential T cell response in central and peripheral nerve injury: connection with immune privilege. FASEB J. 1999;13:1207–1217. doi: 10.1096/fasebj.13.10.1207. [DOI] [PubMed] [Google Scholar]

[CR100_Ref] 100.Muir DA, Compston DA. Growth factor stimulation triggers apoptotic cell death in mature oligodendrocytes. J Neurosci Res. 1996;44:1–11. doi: 10.1002/(SICI)1097-4547(19960401)44:1<1::AID-JNR1>3.0.CO;2-L. [DOI] [PubMed] [Google Scholar]

[CR101_Ref] 101.Murray PD, Pavelko KD, Leibowitz J, Lin X, Rodriguez M. CD4(+) and CD8(+) T cells make discrete contributions to demyelination and neurologic disease in a viral model of multiple sclerosis. J Virol. 1998;72:7320–7329. doi: 10.1128/jvi.72.9.7320-7329.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR102_Ref] 102.Nait-Oumesmar B, Decker L, Lachapelle F, Avellana-Adalid V, Bachelin C, Van Evercooren AB. Progenitor cells of the adult mouse subventricular zone proliferate, migrate and differentiate into oligodendrocytes after demyelination. Eur J Neurosci. 1999;11:4357–4366. doi: 10.1046/j.1460-9568.1999.00873.x. [DOI] [PubMed] [Google Scholar]

[CR103_Ref] 103.Nait-Oumesmar B, Picard-Riera N, Kerninon C, Decker L, Seilhean D, Hoglinger GU, Hirsch EC, Reynolds R, Baron-Van Evercooren A. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors. Proc Natl Acad Sci USA. 2007;104:4694–4699. doi: 10.1073/pnas.0606835104. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR104_Ref] 104.Njenga MK, Murray PD, McGavern D, Lin X, Drescher KM, Rodriguez M. Absence of spontaneous central nervous system remyelination in class II-deficient mice infected with Theiler’s virus. J Neuropathol Exp Neurol. 1999;58:78–91. doi: 10.1097/00005072-199901000-00009. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR105_Ref] 105.Noble M, Murray K, Stroobant P, Waterfield MD, Riddle P. Platelet-derived growth fac- tor promotes division and motility and inhibits premature differentiation of the oligodendrocyte/ type-2 astrocyte progenitor cell. Nature. 1988;333:560–562. doi: 10.1038/333560a0. [DOI] [PubMed] [Google Scholar]

[CR106_Ref] 106.Noseworthy JH, Gold R, Hartung HP. Treatment of multiple sclerosis: recent trials and future perspectives. Curr Opin Neurol. 1999;12:279–293. doi: 10.1097/00019052-199906000-00007. [DOI] [PubMed] [Google Scholar]

[CR107_Ref] 107.Nunes MC, Roy NS, Keyoung HM, Goodman RR, McKhann G, 2nd, Jiang L, Kang J, Nedergaard M, Goldman SA. Identification and isolation of multipotential neural progenitor cells from the subcortical white matter of the adult human brain. Nat Med. 2003;9:439–447. doi: 10.1038/nm837. [DOI] [PubMed] [Google Scholar]

[CR108_Ref] 108.Pannu R, Christie DK, Barbosa E, Singh I, Singh AK. Post-trauma Lipitor treatment prevents endothelial dysfunction, facilitates neuroprotection, and promotes locomotor recovery following spinal cord injury. J Neurochem. 2007;101:182–200. doi: 10.1111/j.1471-4159.2006.04354.x. [DOI] [PubMed] [Google Scholar]

[CR109_Ref] 109.Patrikios P, Stadelmann C, Kutzelnigg A, Rauschka H, Schmidbauer M, Laursen H, Sorensen PS, Bruck W, Lucchinetti C, Lassmann H. Remyelination is extensive in a subset of multiple sclerosis patients. Brain. 2006;129:3165–3172. doi: 10.1093/brain/awl217. [DOI] [PubMed] [Google Scholar]

[CR110_Ref] 110.Pavelko KD, van Engelen BG, Rodriguez M. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci. 1998;18:2498–2505. doi: 10.1523/JNEUROSCI.18-07-02498.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR111_Ref] 111.Paz Soldan MM, Warrington AE, Bieber AJ, Ciric B, Van Keulen V, Pease LR, Rodriguez M. Remyelination-promoting antibodies activate distinct Ca2+ influx pathways in astrocytes and oligodendrocytes: relationship to the mechanism of myelin repair. Mol Cell Neurosci. 2003;22:14–24. doi: 10.1016/S1044-7431(02)00018-0. [DOI] [PubMed] [Google Scholar]

[CR112_Ref] 112.Penderis J, Shields SA, Franklin RJ. Impaired remyelination and depletion of oligodendrocyte progenitors does not occur following repeated episodes of focal demyelination in the rat central nervous system. Brain. 2003;126:1382–1391. doi: 10.1093/brain/awg126. [DOI] [PubMed] [Google Scholar]

[CR113_Ref] 113.Perier O, Gregoire A. Electron microscopic features of multiple sclerosis lesions. Brain. 1965;88:937–952. doi: 10.1093/brain/88.5.937. [DOI] [PubMed] [Google Scholar]

[CR114_Ref] 114.Pirko I, Ciric B, Gamez J, Bieber AJ, Warrington AE, Johnson AJ, Hanson DP, Pease LR, Macura SI, Rodriguez M. A human antibody that promotes remyelination enters the CNS and decreases lesion load as detected by T2-weighted spinal cord MRI in a virusinduced murine model of MS. FASEB J. 2004;18:1577–1579. doi: 10.1096/fj.04-2026fje. [DOI] [PubMed] [Google Scholar]

[CR115_Ref] 115.Pluchino S, Quattrini A, Brambilla E, Gritti A, Salani G, Dina G, Galli R, Del Carro U, Amadio S, Bergami A, Furlan R, Comi G, Vescovi AL, Martino G. Injection of adult neurospheres induces recovery in a chronic model of multiple sclerosis. Nature. 2003;422:688–694. doi: 10.1038/nature01552. [DOI] [PubMed] [Google Scholar]

[CR116_Ref] 116.Prabhakar S, D’Souza S, Antel JP, McLaurin J, Schipper HM, Wang E. Phenotypic and cell cycle properties of human oligodendrocytes in vitro. Brain Res. 1995;672:159–169. doi: 10.1016/0006-8993(94)01377-T. [DOI] [PubMed] [Google Scholar]

[CR117_Ref] 117.Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol. 1993;33:137–151. doi: 10.1002/ana.410330203. [DOI] [PubMed] [Google Scholar]

[CR118_Ref] 118.Prineas JW, Wright RG. Macrophages, lymphocytes, and plasma cells in the perivascular compartment in chronic multiple sclerosis. Lab Invest. 1978;38:409–421. [PubMed] [Google Scholar]

[CR119_Ref] 119.Qian X, Davis AA, Goderie SK, Temple S. FGF2 concentration regulates the generation of neurons and glia from multipotent cortical stem cells. Neuron. 1997;18:81–93. doi: 10.1016/S0896-6273(01)80048-9. [DOI] [PubMed] [Google Scholar]

[CR120_Ref] 120.Raine CS, Stone SH. Animal model for multiple sclerosis. Chronic experimental allergic encephalomyelitis in inbred guinea pigs. N Y State J Med. 1977;77:1693–1696. [PubMed] [Google Scholar]

[CR121_Ref] 121.Rapalino O, Lazarov-Spiegler O, Agranov E, Velan GJ, Yoles E, Fraidakis M, Solomon A, Gepstein R, Katz A, Belkin M, Hadani M, Schwartz M. Implantation of stimulated homologous macrophages results in partial recovery of paraplegic rats. Nat Med. 1998;4:814–821. doi: 10.1038/nm0798-814. [DOI] [PubMed] [Google Scholar]

[CR122_Ref] 122.Rapraeger AC, Krufka A, Olwin BB. Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science. 1991;252:1705–1758. doi: 10.1126/science.1646484. [DOI] [PubMed] [Google Scholar]

[CR123_Ref] 123.Richardson WD, Pringle N, Mosley MJ, Westermark B, Dubois-Dalcq M. A role for platelet-derived growth factor in normal gliogenesis in the central nervous system. Cell. 1988;53:309–319. doi: 10.1016/0092-8674(88)90392-3. [DOI] [PubMed] [Google Scholar]

[CR124_Ref] 124.Riggott MJ, Matthew WD. Neurite outgrowth is enhanced by anti-idiotypic monoclonal antibodies to the ganglioside GM1. Exp Neurol. 1997;145:278–287. doi: 10.1006/exnr.1997.6459. [DOI] [PubMed] [Google Scholar]

[CR125_Ref] 125.Rivera-Quinones C, McGavern D, Schmelzer JD, Hunter SF, Low PA, Rodriguez M. Absence of neurological deficits following extensive demyelination in a class I-deficient murine model of multiple sclerosis. Nat Med. 1998;4:187–193. doi: 10.1038/nm0298-187. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR126_Ref] 126.Robinson S, Tani M, Strieter RM, Ransohoff RM, Miller RH. The chemokine growthregulated oncogene-alpha promotes spinal cord oligodendrocyte precursor proliferation. J Neurosci. 1998;18:10457–10563. doi: 10.1523/JNEUROSCI.18-24-10457.1998. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR127_Ref] 127.Rodriguez M. Immunoglobulins stimulate central nervous system remyelination: electron microscopic and morphometric analysis of proliferating cells. Lab Invest. 1991;64:358–370. [PubMed] [Google Scholar]

[CR128_Ref] 128.Rodriguez M. A function of myelin is to protect axons from subsequent injury: implications for deficits in multiple sclerosis. Brain. 2003;126:751–752. doi: 10.1093/brain/awg070. [DOI] [PubMed] [Google Scholar]

[CR129_Ref] 129.Rodriguez M. Effectors of demyelination and remyelination in the CNS: Implications for multiple sclerosis. Brain Pathol. 2007;17:219–229. doi: 10.1111/j.1750-3639.2007.00065.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR130_Ref] 130.Rodriguez M, Karnes WE, Bartleson JD, Pineda AA. Plasmapheresis in acute episodes of fulminant CNS inflammatory demyelination. Neurology. 1993;43:1100–1104. doi: 10.1212/wnl.43.6.1100. [DOI] [PubMed] [Google Scholar]

[CR131_Ref] 131.Rodriguez M, Lennon VA. Immunoglobulins promote remyelination in the central nervous system. Ann Neurol. 1990;27:12–17. doi: 10.1002/ana.410270104. [DOI] [PubMed] [Google Scholar]

[CR132_Ref] 132.Rodriguez M, Lennon VA, Benveniste EN, Merrill JE. Remyelination by oligodendrocytes stimulated by antiserum to spinal cord. J Neuropathol Exp Neurol. 1987;46:84–95. doi: 10.1097/00005072-198701000-00008. [DOI] [PubMed] [Google Scholar]

[CR133_Ref] 133.Rodriguez M, Miller DJ, Lennon VA. Immunoglobulins reactive with myelin basic protein promote CNS remyelination. Neurology. 1996;46:538–545. doi: 10.1212/wnl.46.2.538. [DOI] [PubMed] [Google Scholar]

[CR134_Ref] 134.Rodriguez M, Oleszak E, Leibowitz J. Theiler’s murine encephalomyelitis: a model of demyelination and persistence of virus. Crit Rev Immunol. 1987;7:325–365. [PubMed] [Google Scholar]

[CR135_Ref] 135.Rodriguez M, Scheithauer BW, Forbes G, Kelly PJ. Oligodendrocyte injury is an early event in lesions of multiple sclerosis. Mayo Clin Proc. 1993;68:627–636. doi: 10.1016/s0025-6196(12)60597-7. [DOI] [PubMed] [Google Scholar]

[CR136_Ref] 136.Rubin BP, Dusart I, Schwab ME. A monoclonal antibody (IN-1) which neutralizes neurite growth inhibitory proteins in the rat CNS recognizes antigens localized in CNS myelin. J Neurocytol. 1994;23:209–217. doi: 10.1007/BF01275525. [DOI] [PubMed] [Google Scholar]

[CR137_Ref] 137.Sasaki M, Honmou O, Akiyama Y, Uede T, Hashi K, Kocsis JD. Transplantation of an acutely isolated bone marrow fraction repairs demyelinated adult rat spinal cord axons. Glia. 2001;35:26–34. doi: 10.1002/glia.1067. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR138_Ref] 138.Schluesener HJ, Sobel RA, Linington C, Weiner HL. A monoclonal antibody against a myelin oligodendrocyte glycoprotein induces relapses and demyelination in central nervous system autoimmune disease. J Immunol. 1987;139:4016–4021. [PubMed] [Google Scholar]

[CR139_Ref] 139.Schwab ME. Structural plasticity of the adult CNS. Negative control by neurite growth inhibitory signals. Int J Dev Neurosci. 1996;14:379–385. doi: 10.1016/0736-5748(96)00024-X. [DOI] [PubMed] [Google Scholar]

[CR140_Ref] 140.Schwartz M, Moalem G, Leibowitz-Amit R, Cohen IR. Innate and adaptive immune responses can be beneficial for CNS repair. Trends Neurosci. 1999;22:295–299. doi: 10.1016/S0166-2236(99)01405-8. [DOI] [PubMed] [Google Scholar]

[CR141_Ref] 141.Setzu A, Lathia JD, Zhao C, Wells K, Rao MS, Ffrench-Constant C, Franklin RJ. Inflammation stimulates myelination by transplanted oligodendrocyte precursor cells. Glia. 2006;54:297–303. doi: 10.1002/glia.20371. [DOI] [PubMed] [Google Scholar]

[CR142_Ref] 142.Sindic CJ, Cambiaso CL, Depre A, Laterre EC, Masson PL. The concentration of IgM in the cerebrospinal fluid of neurological patients. J Neurol Sci. 1982;55:339–350. doi: 10.1016/0022-510X(82)90131-9. [DOI] [PubMed] [Google Scholar]

[CR143_Ref] 143.Sindic CJ, Monteyne P, Laterre EC. Occurrence of oligoclonal IgM bands in the cerebrospinal fluid of neurological patients: an immunoaffinity-mediated capillary blot study. J Neurol Sci. 1994;124:215–219. doi: 10.1016/0022-510X(94)90329-8. [DOI] [PubMed] [Google Scholar]

[CR144_Ref] 144.Smith EJ, Blakemore WF, McDonald WI. Central remyelination restores secure conduction. Nature. 1979;280:395–396. doi: 10.1038/280395a0. [DOI] [PubMed] [Google Scholar]

[CR145_Ref] 145.Sommer I, Schachner M. Monoclonal antibodies (O1 to O4) to oligodendrocyte cell surfaces: an immunocytological study in the central nervous system. Dev Biol. 1981;83:311–327. doi: 10.1016/0012-1606(81)90477-2. [DOI] [PubMed] [Google Scholar]

[CR146_Ref] 146.Spirman N, Sela BA, Gitler C, Calef E, Schwartz M. Regenerative capacity of the goldfish visual system is affected by antibodies specific to gangliosides injected intraocularly. J Neuroimmunol. 1984;6:197–207. doi: 10.1016/0165-5728(84)90006-7. [DOI] [PubMed] [Google Scholar]

[CR147_Ref] 147.Spirman N, Sela BA, Schwartz M. Antiganglioside antibodies inhibit neuritic outgrowth from regenerating goldfish retinal explants. J Neurochem. 1982;39:874–877. doi: 10.1111/j.1471-4159.1982.tb07974.x. [DOI] [PubMed] [Google Scholar]

[CR148_Ref] 148.Stohlman SA, Hinton DR. Viral induced demyelination. Brain Pathol. 2001;11:92–106. doi: 10.1111/j.1750-3639.2001.tb00384.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR149_Ref] 149.Suzuki K, Andrews JM, Waltz JM, Terry RD. Ultrastructural studies of multiple sclerosis. Lab Invest. 1969;20:444–454. [PubMed] [Google Scholar]

[CR150_Ref] 150.Teitelbaum D, Aharoni R, Sela M, Arnon R. Cross-reactions and specificities of monoclonal antibodies against myelin basic protein and against the synthetic copolymer 1. Proc Natl Acad Sci U S A. 1991;88:9528–9532. doi: 10.1073/pnas.88.21.9528. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR151_Ref] 151.Totoiu MO, Nistor GI, Lane TE, Keirstead HS. Remyelination, axonal sparing, and locomotor recovery following transplantation of glial-committed progenitor cells into the MHV model of multiple sclerosis. Exp Neurol. 2004;187:254–265. doi: 10.1016/j.expneurol.2004.01.028. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR152_Ref] 152.Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med. 1998;338:278–285. doi: 10.1056/NEJM199801293380502. [DOI] [PubMed] [Google Scholar]

[CR153_Ref] 153.Tripathi R, McTigue DM. Prominent oligodendrocyte genesis along the border of spinal contusion lesions. Glia. 2007;55:698–711. doi: 10.1002/glia.20491. [DOI] [PubMed] [Google Scholar]

[CR154_Ref] 154.Ure DR, Rodriguez M. Polyreactive antibodies to glatiramer acetate promote myelin repair in murine model of demyelinating disease. FASEB J. 2002;16:1260–1262. doi: 10.1096/fj.01-1023fje. [DOI] [PubMed] [Google Scholar]

[CR155_Ref] 155.Ure DR, Rodriguez M. Preservation of neurologic function during inflammatory demyelination correlates with axon sparing in a mouse model of multiple sclerosis. Neuroscience. 2002;111:399–411. doi: 10.1016/S0306-4522(02)00012-X. [DOI] [PubMed] [Google Scholar]

[CR156_Ref] 156.Utzschneider DA, Archer DR, Kocsis JD, Waxman SG, Duncan ID. Transplantation of glial cells enhances action potential conduction of amyelinated spinal cord axons in the myelin-deficient rat. Proc Natl Acad Sci U S A. 1994;91:53–57. doi: 10.1073/pnas.91.1.53. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR157_Ref] 157.Vartanian T, Fischbach G, Miller R. Failure of spinal cord oligodendrocyte development in mice lacking neuregulin. Proc Natl Acad Sci U S A. 1999;96:731–735. doi: 10.1073/pnas.96.2.731. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR158_Ref] 158.Vieira P, Rajewsky K. The half-lives of serum immunoglobulins in adult mice. Eur J Immunol. 1988;18:313–316. doi: 10.1002/eji.1830180221. [DOI] [PubMed] [Google Scholar]

[CR159_Ref] 159.Vincent A, Lily O, Palace J. Pathogenic autoantibodies to neuronal proteins in neurological disorders. J Neuroimmunol. 1999;100:169–180. doi: 10.1016/S0165-5728(99)00210-6. [DOI] [PubMed] [Google Scholar]

[CR160_Ref] 160.Vyas AA, Patel HV, Fromholt SE, Heffer-Lauc M, Vyas KA, Dang J, Schachner M, Schnaar RL. Gangliosides are functional nerve cell ligands for myelin-associated glycoprotein (MAG), an inhibitor of nerve regeneration. Proc Natl Acad Sci U S A. 2002;99:8412–8417. doi: 10.1073/pnas.072211699. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR161_Ref] 161.Warrington AE, Asakura K, Bieber AJ, Ciric B, Van Keulen V, Kaveri SV, Kyle RA, Pease LR, Rodriguez M. Human monoclonal antibodies reactive to oligodendrocytes promote remyelination in a model of multiple sclerosis. Proc Natl Acad Sci USA. 2000;97:6820–6825. doi: 10.1073/pnas.97.12.6820. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR162_Ref] 162.Warrington AE, Barbarese E, Pfeiffer SE. Differential myelinogenic capacity of specific developmental stages of the oligodendrocyte lineage upon transplantation into hypomyelinating hosts. J Neurosci Res. 1993;34:1–13. doi: 10.1002/jnr.490340102. [DOI] [PubMed] [Google Scholar]

[CR163_Ref] 163.Warrington AE, Bieber AJ, Ciric B, Pease LR, Van Keulen V, Rodriguez M. A recombinant human IgM promotes myelin repair after a single, very low dose. J Neurosci Res. 2007;85:967–976. doi: 10.1002/jnr.21217. [DOI] [PubMed] [Google Scholar]

[CR164_Ref] 164.Warrington AE, Bieber AJ, Van Keulen V, Ciric B, Pease LR, Rodriguez M. Neuronbinding human monoclonal antibodies support central nervous system neurite extension. J Neuropathol Exp Neurol. 2004;63:461–473. doi: 10.1093/jnen/63.5.461. [DOI] [PubMed] [Google Scholar]

[CR165_Ref] 165.Warrington AE, Pfeiffer SE. Proliferation and differentiation of O4+ oligodendrocytes in postnatal rat cerebellum: analysis in unfixed tissue slices using anti-glycolipid antibodies. J Neurosci Res. 1992;33:338–353. doi: 10.1002/jnr.490330218. [DOI] [PubMed] [Google Scholar]

[CR166_Ref] 166.Weibel D, Cadelli D, Schwab ME. Regeneration of lesioned rat optic nerve fibers is improved after neutralization of myelin-associated neurite growth inhibitors. Brain Res. 1994;642:259–266. doi: 10.1016/0006-8993(94)90930-X. [DOI] [PubMed] [Google Scholar]

[CR167_Ref] 167.Weinshenker BG, O’Brien PC, Petterson TM, Noseworthy JH, Lucchinetti CF, Dodick DW, Pineda AA, Stevens LN, Rodriguez M. A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol. 1999;46:878–886. doi: 10.1002/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q. [DOI] [PubMed] [Google Scholar]

[CR168_Ref] 168.Weinshenker BG, Wingerchuk DM, Pittock SJ, Lucchinetti CF, Lennon VA. NMOIgG: a specific biomarker for neuromyelitis optica. Dis Markers. 2006;22:197–206. doi: 10.1155/2006/586306. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR169_Ref] 169.Windrem MS, Nunes MC, Rashbaum WK, Schwartz TH, Goodman RA, McKhann G, 2nd, Roy NS, Goldman SA. Fetal and adult human oligodendrocyte progenitor cell isolates myelinate the congenitally dysmyelinated brain. Nat Med. 2004;10:93–97. doi: 10.1038/nm974. [DOI] [PubMed] [Google Scholar]

[CR170_Ref] 170.Wolswijk G. Oligodendrocyte precursor cells in chronic multiple sclerosis lesions. Mult Scler. 1997;3:168–169. doi: 10.1177/135245859700300221. [DOI] [PubMed] [Google Scholar]

[CR171_Ref] 171.Woodruff RH, Franklin RJ. Growth factors and remyelination in the CNS. Histol Histopathol. 1997;12:459–466. [PubMed] [Google Scholar]

[CR172_Ref] 172.Yajima K, Suzuki K. Demyelination and remyelination in the rat central nervous system following ethidium bromide injection. Lab Invest. 1979;41:385–392. [PubMed] [Google Scholar]

[CR173_Ref] 173.Yandava BD, Billinghurst LL, Snyder EY. “Global” cell replacement is feasible via neural stem cell transplantation: evidence from the dysmyelinated shiverer mouse brain. Proc Natl Acad Sci U S A. 1999;96:7029–7034. doi: 10.1073/pnas.96.12.7029. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR174_Ref] 174.Yao DL, Liu X, Hudson LD, Webster HD. Insulin-like growth factor I treatment reduces demyelination and up-regulates gene expression of myelin-related proteins in experimental autoimmune encephalomyelitis. Proc Natl Acad Sci U S A. 1995;92:6190–194. doi: 10.1073/pnas.92.13.6190. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR175_Ref] 175.Yoles E, Hauben E, Palgi O, Agranov E, Gothilf A, Cohen A, Kuchroo V, Cohen IR, Weiner H, Schwartz M. Protective autoimmunity is a physiological response to CNS trauma. J Neurosci. 2001;21:3740–3748. doi: 10.1523/JNEUROSCI.21-11-03740.2001. [DOI] [PMC free article] [PubMed] [Google Scholar]

[CR176_Ref] 176.Ziemssen T, Ziemssen F. The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE) Autoimmun Rev. 2005;4:460–467. doi: 10.1016/j.autrev.2005.03.005. [DOI] [PubMed] [Google Scholar]

PERMALINK

Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease

A E Warrington

M Rodriguez

Abstract

Contributor Information

References

ACTIONS

PERMALINK

RESOURCES

Cite

Add to Collections

PERMALINK

Remyelination-Promoting Human IgMs: Developing a Therapeutic Reagent for Demyelinating Disease

A E Warrington

M Rodriguez

Abstract

Contributor Information

References

ACTIONS

PERMALINK

RESOURCES

Similar articles

Cited by other articles

Links to NCBI Databases